A New FDA Approved Drug Available for AML Patients

A New FDA Approved Drug Available for AML Patients

A new treatment is available for patients suffering from acute myeloid leukemia. The name of the drug is Idhifa and it has been developed by the Celgene Corp and the Angios Pharmaceuticals Inc. Celgene releases a statement According to the…